TCR Gene Therapy of Spontaneous Prostate Carcinoma Requires In Vivo T Cell Activation-Reference-Cited by-同舟云学术

TCR Gene Therapy of Spontaneous Prostate Carcinoma Requires In Vivo T Cell Activation

Published:2008-08-06 Issue:4 Volume:181 Page:2563-2571
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

de Witte Moniek A.,Bendle Gavin M.,van den Boom Marly D.,Coccoris Miriam,Schell Todd D.,Tevethia Satvir S.,van Tinteren Harm,Mesman Elly M.,Song Ji-Ying,Schumacher Ton N. M.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance

2. Breaking tolerance in cancer immunotherapy: time to ACT

3. Monoclonal antibody therapy of cancer

4. Selective elimination of leukemic CD34+ progenitor cells by cytotoxic T lymphocytes specific for WT1

5. Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adoptive T cell therapy of solid tumors: time to team up with immunogenic chemo/radiotherapy;Current Opinion in Immunology;2022-02

2. Tumor-Resident Dendritic Cells and Macrophages Modulate the Accumulation of TCR-Engineered T Cells in Melanoma;Molecular Therapy;2018-06

3. The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer;Frontiers in Immunology;2018-04-20

4. Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy;Clinical Cancer Research;2018-02-28

5. T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors;Cancer Research;2016-11-21